An artificial intelligence platform could do away with the need for placebos in clinical trials for new drugs. Medidata, which analyses results from clinical trials for the world's leading drugs makers, has developed a machine-learning system that could overhaul the testing of experimental treatments.
An artificial intelligence platform could do away with the need for placebos in clinical trials for new drugs. Medidata, which analyses results from clinical trials for the world's leading drugs makers, has developed a machine-learning system that could overhaul the testing of experimental treatments.
No comments:
Post a Comment